Your browser doesn't support javascript.
loading
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece.
Barmpouni, Myrto; Gordon, Jason P; Miller, Ryan L; Dennis, James W; Grammelis, Vassilis; Rousakis, Aris; Souliotis, Kyriakos; Poulakou, Garyphallia; Daikos, George L; Al-Taie, Amer.
Afiliação
  • Barmpouni M; Pfizer Hellas, Athens, Greece.
  • Gordon JP; Health Economics and Outcomes Research Ltd., Cardiff, UK.
  • Miller RL; Health Economics and Outcomes Research Ltd., Cardiff, UK.
  • Dennis JW; Health Economics and Outcomes Research Ltd., Cardiff, UK.
  • Grammelis V; Pfizer Hellas, Athens, Greece.
  • Rousakis A; Pfizer Hellas, Athens, Greece.
  • Souliotis K; Faculty of Social and Political Sciences, University of Peloponnese, Corinth, Greece.
  • Poulakou G; Health Policy Institute, Athens, Greece.
  • Daikos GL; 3rd Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria General Hospital, Athens, Greece.
  • Al-Taie A; National and Kapodistrian University of Athens, Athens, Greece.
Infect Dis Ther ; 12(7): 1891-1905, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37410343
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Ano de publicação: 2023 Tipo de documento: Article